IMPACT OF METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE ON THE INCIDENCE OF OSTEOPOROSIS

被引：0
|
作者：
Khan, Wajiha [1 ]
Kim, David [1 ]
Shari, Ariana [1 ]
Khan, Hamza [1 ]
Le, Alexander [1 ]
Hawryluk, Christopher [1 ]
Bobkov, Ivan [1 ]
Al-Khazraji, Ahmed [1 ]
Hajifathalian, Kaveh [1 ]
机构：
[1] Rutgers New Jersey Med Sch, Newark, NJ USA
来源：
HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1082
引用
收藏
页码：S819 / S820
页数：2
相关论文
共 50 条
  • [31] Hepatocellular Carcinoma in Metabolic Dysfunction-Associated Steatotic Liver Disease
    Rodriguez, Luis A.
    Schmittdiel, Julie A.
    Liu, Liyan
    Macdonald, Brock A.
    Balasubramanian, Sreepriya
    Chai, Krisna P.
    Seo, Suk I.
    Mukhtar, Nizar
    Levin, Theodore R.
    Saxena, Varun
    JAMA NETWORK OPEN, 2024, 7 (07) : e2421019
  • [32] Metabolic dysfunction-associated steatotic liver disease and risk of cardiovascular disease
    Lee, Hyeok-Hee
    Lee, Han Ah
    Kim, Eun-Jin
    Kim, Hwi Young
    Kim, Hyeon Chang
    Ahn, Sang Hoon
    Lee, Hokyou
    Kim, Seung Up
    GUT, 2024, 73 (03) : 533 - 540
  • [33] Monitoring disease progression in metabolic dysfunction-associated steatotic liver disease
    Noureddin, Nabil
    Copur-Dahi, Nedret
    Loomba, Rohit
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 59 : S41 - S51
  • [34] The Impact of Japanese Dietary Patterns on Metabolic Dysfunction-Associated Steatotic Liver Disease and Liver Fibrosis
    Sasada, Takafumi
    Iino, Chikara
    Sato, Satoshi
    Tateda, Tetsuyuki
    Igarashi, Go
    Yoshida, Kenta
    Sawada, Kaori
    Mikami, Tatsuya
    Nakaji, Shigeyuki
    Sakuraba, Hirotake
    Fukuda, Shinsaku
    NUTRIENTS, 2024, 16 (17)
  • [35] What is the impact of metabolic dysfunction-associated steatotic liver disease on drug transport and metabolism?
    Dietrich, Christoph G.
    Geier, Andreas
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2024, 20 (03) : 107 - 110
  • [36] Implications of the new nomenclature of steatotic liver disease and definition of metabolic dysfunction-associated steatotic liver disease
    Loomba, Rohit
    Wong, Vincent Wai-Sun
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 59 (02) : 150 - 156
  • [37] Racial disparities in incidence of cirrhosis and extrahepatic manifestations in metabolic dysfunction-associated steatotic liver disease
    Aboona, Majd
    Ghani, Leith
    Rangan, Pooja
    Chen, Vincent
    Ng, Cheng Han
    Huang, Daniel
    Muthiah, Mark
    Kim, Donghee
    Rubin, Moises Nevah
    Han, Ma Ai Thanda
    Fallon, Michael
    Wijarnpreecha, Karn
    JOURNAL OF HEPATOLOGY, 2024, 80 : S478 - S478
  • [38] Metabolic dysfunction-associated steatotic liver disease related cirrhosis and incidence of portal vein thrombosis
    Amjad, Waseem
    Jiang, Zhenghui G.
    Lai, Michelle
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2024, 36 (08) : 1038 - 1045
  • [39] Australians with metabolic dysfunction-associated steatotic liver disease have a twofold increase in the incidence of cancer
    Powell, Elizabeth E.
    Roche, Shruti
    Sarraf, Babak
    Hartel, Gunter
    Skoien, Richard
    Leggett, Barbara
    O'Beirne, James
    Valery, Patricia C.
    JGH OPEN, 2024, 8 (07):
  • [40] Gut microbiota and metabolic biomarkers in metabolic dysfunction-associated steatotic liver disease
    Long, Qichen
    Luo, Fengming
    Li, Binghui
    Li, Ziyang
    Guo, Zhe
    Chen, Zhiyang
    Wu, Weimin
    Hu, Min
    HEPATOLOGY COMMUNICATIONS, 2024, 8 (03)
12345